Structure-based design, synthesis, and biochemical and pharmacological characterization of novel salvinorin A analogues as active state probes of the κ-opioid receptor

Feng Yan, Ruslan V. Bikbulatov, Viorel Mocanu, Nedyalka Dicheva, Carol E. Parker, William C. Wetsel, Philip D. Mosier, Richard B. Westkaemper, John Allen, Jordan K. Zjawiony, Bryan L. Roth

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Salvinorin A, the most potent naturally occurring hallucinogen, has attracted an increasing amount of attention since the κ-opioid receptor (KOR) was identified as its principal molecular target by us [Roth, B. L., et al. (2002) Proc. Natl. Acad. Sci. U.S.A. 99, 11934-11939]. Here we report the design, synthesis, and biochemical characterization of novel, irreversible, salvinorin A-derived ligands suitable as active state probes of the KOR. On the basis of prior substituted cysteine accessibility and molecular modeling studies, C3157.38 was chosen as a potential anchoring point for covalent labeling of salvinorin A-derived ligands. Automated docking of a series of potential covalently bound ligands suggested that either a haloacetate moiety or other similar electrophilic groups could irreversibly bind with C3157.38. 22-Thiocyanatosalvinorin A (RB-64) and 22-chlorosalvinorin A (RB-48) were both found to be extraordinarily potent and selective KOR agonists in vitro and in vivo. As predicted on the basis of molecular modeling studies, RB-64 induced wash-resistant inhibition of binding with a strict requirement for a free cysteine in or near the binding pocket. Mass spectrometry (MS) studies utilizing synthetic KOR peptides and RB-64 supported the hypothesis that the anchoring residue was C3157.38 and suggested one biochemical mechanism for covalent binding. These studies provide direct evidence of the presence of a free cysteine in the agonist-bound state of the KOR and provide novel insights into the mechanism by which salvinorin A binds to and activates the KOR.

Original languageEnglish (US)
Pages (from-to)6898-6908
Number of pages11
JournalBiochemistry
Volume48
Issue number29
DOIs
StatePublished - Jul 28 2009
Externally publishedYes

Fingerprint

salvinorin A
Opioid Receptors
Pharmacology
Cysteine
Molecular modeling
Ligands
Hallucinogens
Labeling
Mass spectrometry
Mass Spectrometry
Peptides
22-thiocyanatosalvinorin A

ASJC Scopus subject areas

  • Biochemistry

Cite this

Structure-based design, synthesis, and biochemical and pharmacological characterization of novel salvinorin A analogues as active state probes of the κ-opioid receptor. / Yan, Feng; Bikbulatov, Ruslan V.; Mocanu, Viorel; Dicheva, Nedyalka; Parker, Carol E.; Wetsel, William C.; Mosier, Philip D.; Westkaemper, Richard B.; Allen, John; Zjawiony, Jordan K.; Roth, Bryan L.

In: Biochemistry, Vol. 48, No. 29, 28.07.2009, p. 6898-6908.

Research output: Contribution to journalArticle

Yan, F, Bikbulatov, RV, Mocanu, V, Dicheva, N, Parker, CE, Wetsel, WC, Mosier, PD, Westkaemper, RB, Allen, J, Zjawiony, JK & Roth, BL 2009, 'Structure-based design, synthesis, and biochemical and pharmacological characterization of novel salvinorin A analogues as active state probes of the κ-opioid receptor', Biochemistry, vol. 48, no. 29, pp. 6898-6908. https://doi.org/10.1021/bi900605n
Yan, Feng ; Bikbulatov, Ruslan V. ; Mocanu, Viorel ; Dicheva, Nedyalka ; Parker, Carol E. ; Wetsel, William C. ; Mosier, Philip D. ; Westkaemper, Richard B. ; Allen, John ; Zjawiony, Jordan K. ; Roth, Bryan L. / Structure-based design, synthesis, and biochemical and pharmacological characterization of novel salvinorin A analogues as active state probes of the κ-opioid receptor. In: Biochemistry. 2009 ; Vol. 48, No. 29. pp. 6898-6908.
@article{d3e008e182dd4d0d80f292a18c7bde58,
title = "Structure-based design, synthesis, and biochemical and pharmacological characterization of novel salvinorin A analogues as active state probes of the κ-opioid receptor",
abstract = "Salvinorin A, the most potent naturally occurring hallucinogen, has attracted an increasing amount of attention since the κ-opioid receptor (KOR) was identified as its principal molecular target by us [Roth, B. L., et al. (2002) Proc. Natl. Acad. Sci. U.S.A. 99, 11934-11939]. Here we report the design, synthesis, and biochemical characterization of novel, irreversible, salvinorin A-derived ligands suitable as active state probes of the KOR. On the basis of prior substituted cysteine accessibility and molecular modeling studies, C3157.38 was chosen as a potential anchoring point for covalent labeling of salvinorin A-derived ligands. Automated docking of a series of potential covalently bound ligands suggested that either a haloacetate moiety or other similar electrophilic groups could irreversibly bind with C3157.38. 22-Thiocyanatosalvinorin A (RB-64) and 22-chlorosalvinorin A (RB-48) were both found to be extraordinarily potent and selective KOR agonists in vitro and in vivo. As predicted on the basis of molecular modeling studies, RB-64 induced wash-resistant inhibition of binding with a strict requirement for a free cysteine in or near the binding pocket. Mass spectrometry (MS) studies utilizing synthetic KOR peptides and RB-64 supported the hypothesis that the anchoring residue was C3157.38 and suggested one biochemical mechanism for covalent binding. These studies provide direct evidence of the presence of a free cysteine in the agonist-bound state of the KOR and provide novel insights into the mechanism by which salvinorin A binds to and activates the KOR.",
author = "Feng Yan and Bikbulatov, {Ruslan V.} and Viorel Mocanu and Nedyalka Dicheva and Parker, {Carol E.} and Wetsel, {William C.} and Mosier, {Philip D.} and Westkaemper, {Richard B.} and John Allen and Zjawiony, {Jordan K.} and Roth, {Bryan L.}",
year = "2009",
month = "7",
day = "28",
doi = "10.1021/bi900605n",
language = "English (US)",
volume = "48",
pages = "6898--6908",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "29",

}

TY - JOUR

T1 - Structure-based design, synthesis, and biochemical and pharmacological characterization of novel salvinorin A analogues as active state probes of the κ-opioid receptor

AU - Yan, Feng

AU - Bikbulatov, Ruslan V.

AU - Mocanu, Viorel

AU - Dicheva, Nedyalka

AU - Parker, Carol E.

AU - Wetsel, William C.

AU - Mosier, Philip D.

AU - Westkaemper, Richard B.

AU - Allen, John

AU - Zjawiony, Jordan K.

AU - Roth, Bryan L.

PY - 2009/7/28

Y1 - 2009/7/28

N2 - Salvinorin A, the most potent naturally occurring hallucinogen, has attracted an increasing amount of attention since the κ-opioid receptor (KOR) was identified as its principal molecular target by us [Roth, B. L., et al. (2002) Proc. Natl. Acad. Sci. U.S.A. 99, 11934-11939]. Here we report the design, synthesis, and biochemical characterization of novel, irreversible, salvinorin A-derived ligands suitable as active state probes of the KOR. On the basis of prior substituted cysteine accessibility and molecular modeling studies, C3157.38 was chosen as a potential anchoring point for covalent labeling of salvinorin A-derived ligands. Automated docking of a series of potential covalently bound ligands suggested that either a haloacetate moiety or other similar electrophilic groups could irreversibly bind with C3157.38. 22-Thiocyanatosalvinorin A (RB-64) and 22-chlorosalvinorin A (RB-48) were both found to be extraordinarily potent and selective KOR agonists in vitro and in vivo. As predicted on the basis of molecular modeling studies, RB-64 induced wash-resistant inhibition of binding with a strict requirement for a free cysteine in or near the binding pocket. Mass spectrometry (MS) studies utilizing synthetic KOR peptides and RB-64 supported the hypothesis that the anchoring residue was C3157.38 and suggested one biochemical mechanism for covalent binding. These studies provide direct evidence of the presence of a free cysteine in the agonist-bound state of the KOR and provide novel insights into the mechanism by which salvinorin A binds to and activates the KOR.

AB - Salvinorin A, the most potent naturally occurring hallucinogen, has attracted an increasing amount of attention since the κ-opioid receptor (KOR) was identified as its principal molecular target by us [Roth, B. L., et al. (2002) Proc. Natl. Acad. Sci. U.S.A. 99, 11934-11939]. Here we report the design, synthesis, and biochemical characterization of novel, irreversible, salvinorin A-derived ligands suitable as active state probes of the KOR. On the basis of prior substituted cysteine accessibility and molecular modeling studies, C3157.38 was chosen as a potential anchoring point for covalent labeling of salvinorin A-derived ligands. Automated docking of a series of potential covalently bound ligands suggested that either a haloacetate moiety or other similar electrophilic groups could irreversibly bind with C3157.38. 22-Thiocyanatosalvinorin A (RB-64) and 22-chlorosalvinorin A (RB-48) were both found to be extraordinarily potent and selective KOR agonists in vitro and in vivo. As predicted on the basis of molecular modeling studies, RB-64 induced wash-resistant inhibition of binding with a strict requirement for a free cysteine in or near the binding pocket. Mass spectrometry (MS) studies utilizing synthetic KOR peptides and RB-64 supported the hypothesis that the anchoring residue was C3157.38 and suggested one biochemical mechanism for covalent binding. These studies provide direct evidence of the presence of a free cysteine in the agonist-bound state of the KOR and provide novel insights into the mechanism by which salvinorin A binds to and activates the KOR.

UR - http://www.scopus.com/inward/record.url?scp=67651204566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651204566&partnerID=8YFLogxK

U2 - 10.1021/bi900605n

DO - 10.1021/bi900605n

M3 - Article

C2 - 19555087

AN - SCOPUS:67651204566

VL - 48

SP - 6898

EP - 6908

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 29

ER -